Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04176705 · ClinicalTrials.gov registry record · NA
Fractional Ablative Laser Treatment for Skin Grafts
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04176705 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 9 participants.
The verdict
NCT04176705, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Doctors and patients refer to all areas of skin changes from burn injury as burn scars. However, different areas of scars from burns can be treated differently. The burn scars that come from skin grafting surgery might be improved with laser treatment. The purpose of this study is to see if treating burn skin graft scars with a laser could make it better. Fractional Ablative Laser has been approved by the US Food and Drug Administration (FDA), but it has not been approved for use in the early stages of scar maturation and is considered investigational for this study.
Interventions
- DRUG Lidocaine Cream
- DRUG Triamcinolone Acetonide Cream
- DEVICE Fractional Ablative Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2023-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04176705
The ClinicalTrials.gov registry entry for NCT04176705 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lidocaine Cream is the first listed.
NCT04176705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04176705 about?
NCT04176705 is a clinical study titled "Fractional Ablative Laser Treatment for Skin Grafts". Doctors and patients refer to all areas of skin changes from burn injury as burn scars. However, different areas of scars from burns can be treated differently. The burn scars that come from skin grafting surgery might be improved with laser treatment. The purpose of this study is to see if treating...
What is the current status of trial NCT04176705?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2020-12-14. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT04176705?
The interventions under investigation include: Lidocaine Cream (DRUG), Triamcinolone Acetonide Cream (DRUG), Fractional Ablative Laser (DEVICE).
Who is sponsoring clinical trial NCT04176705?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.